We are live on ! Find out more
ORGO icon

Organogenesis Holdings

55 hedge funds and large institutions have $19.6M invested in Organogenesis Holdings in 2019 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 19 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

533% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 3

250% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 6

56% more capital invested

Capital invested by funds: $12.5M → $19.6M (+$7.08M)

38% more funds holding

Funds holding: 4055 (+15)

1.91% more ownership

Funds ownership: 2.01%3.92% (+1.9%)

Holders
55
Holders Change
+15
Holders Change %
+37.5%
% of All Funds
1.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
19
Reduced
3
Closed
6
Calls
Puts
Net Calls
Net Calls Change

ORGO Hedge Fund Activity: Q4 2019 in Review

55 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q4 2019, worth a combined $19.6M — up 56% from $12.5M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new ORGO positions and 6 closed out — a net gain of 15 holders — while 19 added to existing stakes and 3 trimmed.

The largest buyer was Prosight Management, opening a new position worth an estimated $3.92M. The largest seller was Angelo Gordon & Co, exiting entirely with an estimated $974K sold.

  • 55 institutional investors held Organogenesis Holdings (ORGO) as of Q4 2019, up from 40 in Q3 2019.
  • Funds reported $19.6M of Organogenesis Holdings stock for Q4 2019, up 56% quarter-over-quarter.
  • 21 funds opened new Organogenesis Holdings positions in Q4 2019 and 6 closed out, a net change of +15 holders.
  • The largest Organogenesis Holdings buyer in Q4 2019 was Prosight Management, an estimated $3.92M added.
  • The largest Organogenesis Holdings seller in Q4 2019 was Angelo Gordon & Co, an estimated $974K sold.

Based on aggregated 13F filings for Q4 2019.